These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 1719308

  • 1. Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemic blast cells from ara-C toxicity.
    Koistinen P, Wang C, Curtis JE, McCulloch EA.
    Leukemia; 1991 Sep; 5(9):789-95. PubMed ID: 1719308
    [Abstract] [Full Text] [Related]

  • 2. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside.
    Koistinen P, Wang C, Yang GS, Wang YF, Williams DE, Lyman SD, Minden MD, McCulloch EA.
    Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961
    [Abstract] [Full Text] [Related]

  • 3. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
    te Boekhorst PA, Löwenberg B, Vlastuin M, Sonneveld P.
    Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
    [Abstract] [Full Text] [Related]

  • 4. Effects of rGM-CSF and rG-CSF on the cisplatin sensitivity of the blast cells of acute myeloblastic leukemia.
    Wang YF, Kelleher CA, Minkin S, McCulloch EA.
    Leukemia; 1991 Mar; 5(3):239-48. PubMed ID: 1707468
    [Abstract] [Full Text] [Related]

  • 5. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells.
    te Boekhorst PA, Löwenberg B, Sonneveld P.
    Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289
    [Abstract] [Full Text] [Related]

  • 6. Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside.
    Yang GS, Minden MD, McCulloch EA.
    Leukemia; 1993 Jul; 7(7):1012-9. PubMed ID: 7686602
    [Abstract] [Full Text] [Related]

  • 7. Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia.
    Cannistra SA, Groshek P, Griffin JD.
    Leukemia; 1989 May; 3(5):328-34. PubMed ID: 2654494
    [Abstract] [Full Text] [Related]

  • 8. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
    Tafuri A, De Felice L, Mascolo MG, Valentini T, Petrucci MT, Petti MC.
    Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
    [Abstract] [Full Text] [Related]

  • 9. Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside.
    Yang GS, Wang C, Minkin S, Minden MD, McCulloch EA.
    J Cell Physiol; 1991 Jul; 148(1):60-7. PubMed ID: 1860896
    [Abstract] [Full Text] [Related]

  • 10. Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs.
    Tafuri A, Lemoli RM, Chen R, Gulati SC, Clarkson BD, Andreeff M.
    Leukemia; 1994 May; 8(5):749-57. PubMed ID: 7514244
    [Abstract] [Full Text] [Related]

  • 11. In vitro response of blasts to IL-3, GM-CSF, and G-CSF is different for individual AML patients: factors that stimulate leukemic clonogenic cells also enhance Ara-C cytotoxicity.
    Van der Lely N, De Witte T, Wessels J, Raymakers R, Muus P, Preijers F.
    Ann Hematol; 1994 May; 68(5):225-32. PubMed ID: 7517190
    [Abstract] [Full Text] [Related]

  • 12. Blast cell proliferative activity and sensitivity to GM-CSF in vitro are associated with early response to TAD-9 induction therapy in acute myeloid leukemia.
    Jahns-Streubel G, Reuter C, Unterhalt M, Schleyer E, Wörmann B, Büchner T, Hiddemann W.
    Leukemia; 1995 Nov; 9(11):1857-63. PubMed ID: 7475275
    [Abstract] [Full Text] [Related]

  • 13. Cytosine arabinoside (ara-C) and cis-dichlorodiammineplatinum II (cisplatin) alone and in combination: effects on acute myeloblastic leukemia blast cells in culture and in vivo.
    Wang YF, Curtis JE, Lipton J, Minkin S, McCulloch EA.
    Leukemia; 1991 Jun; 5(6):522-7. PubMed ID: 1711641
    [Abstract] [Full Text] [Related]

  • 14. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM, Gulati SC, Strife A, Lambek C, Perez A, Clarkson BD.
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [Abstract] [Full Text] [Related]

  • 15. Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy.
    Hu ZB, Minden MD, McCulloch EA.
    Leukemia; 1996 Mar; 10(3):410-6. PubMed ID: 8642855
    [Abstract] [Full Text] [Related]

  • 16. GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cells.
    De Witte T, Muus P, Haanen C, Van der Lely N, Koekman E, Van der Locht A, Blankenborg G, Wessels J.
    Behring Inst Mitt; 1988 Aug; (83):301-7. PubMed ID: 3071344
    [Abstract] [Full Text] [Related]

  • 17. Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cells.
    Grant S, Traylor R, Bhalla K, McCrady C, Pettit GR.
    Leukemia; 1992 May; 6(5):432-9. PubMed ID: 1593908
    [Abstract] [Full Text] [Related]

  • 18. Enhancement by transforming growth factor-beta 1 (TGF-beta 1) of the proliferation of leukemic blast progenitors stimulated with IL-3.
    Suzuki T, Bessho M, Hirashima K, Tohda S, Nagata K, Morio T, Imai Y, Nara N.
    J Cell Physiol; 1991 Sep; 148(3):396-403. PubMed ID: 1717497
    [Abstract] [Full Text] [Related]

  • 19. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.
    Hiddemann W, Kiehl M, Zühlsdorf M, Busemann C, Schleyer E, Wörmann B, Büchner T.
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):31-7. PubMed ID: 1553573
    [Abstract] [Full Text] [Related]

  • 20. Modulation of intracellular metabolism of cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor.
    Reuter C, Auf der Landwehr U, Schleyer E, Zühlsdorf M, Ameling C, Rolf C, Wörmann B, Büchner T, Hiddemann W.
    Leukemia; 1994 Feb; 8(2):217-25. PubMed ID: 8309245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.